Rob van Montford
@ICR_London
about targeting the splicing modulator DHX8 in collaboration with
@merckgroup
. Starting from a weak fragment hit, iterative rounds of structure-based design delivered an oral first-in-class DHX8 inhibitor showing monotherapy efficacy in mice. #AACR26